無限極攜手香港頂尖科研力量 著力多醣領域創新

Infinitus Drives Polysaccharide Innovation with Hong Kong Institutions

2026年11月6日至9日，天然產物國際學會2026年年會於香港浸會大學隆重舉行。本次大會以「天然產物研究與創新驅動」為主題，圍繞天然產物研究新技術、青年學者成長與產業發展等核心議題展開深入交流，旨在搭建跨學科、國際化的合作平台，促進天然產物領域的持續創新與合作。無限極贊助及深度參與了一系列重點學術交流活動，全面展現中草藥科研實力。

The 2026 Annual Conference of the International Society of Natural Products (ISNP 2026) was held at Hong Kong Baptist University (HKBU) from November 6(th) to 9(th) 2026. Under the theme “Natural Products Research and Innovation as the Driving Force”, the conference featured in-depth discussions on key topics, including new technologies in natural products research, early-career researcher development and industrial development. It aimed to provide an interdisciplinary and international platform for collaboration, promoting continued innovation and cooperation in the field of natural products. During the same period, Infinitus sponsored and actively participated in a series of key academic exchange activities, showcasing its research and development capabilities in Chinese herbal medicine.

聚焦頂尖科研 展現多醣研發實力

Spotlight on Cutting-Edge Research and Polysaccharide R&D Capabilities

無限極早在2024年便與香港浸會大學建立了深度的戰略夥伴關係，雙方圍繞中草藥科學領域展開了長期的科研合作，並成立「香港浸會大學─無限極中草藥多醣研究聯合實驗室」。

Infinitus established a strategic partnership with Hong Kong Baptist University in 2024. Since then, the two parties have maintained long-term research collaboration in Chinese herbal medicine science and jointly established the HKBU & Infinitus Joint Laboratory for Chinese Herbal Polysaccharide Research.

香港浸會大學─無限極中草藥多醣研究聯合實驗室

HKBU & Infinitus Joint Laboratory for Chinese Herbal Polysaccharide Research

在11月7日至8日的學術會議環節中，無限極（中國）有限公司前沿技術高級研究員朱穎博士(Dr. Elaine Zhu)向與會嘉賓公開分享了靈芝多醣領域的最新突破：團隊從源頭篩選出優質菌株M624並建立專利溯源體系；工藝上採用「膜過濾+超聲降解」綠色技術，成功製得高水溶性、易吸收、品質穩定的GLP-D靈芝多醣；同時首創「特徵寡醣指紋圖譜」升級整體品質控制標準。此外，研究更揭示了GLP-D多醣調控腸道免疫的關鍵機制，並證實複合多醣配伍在抗感染、抗疲勞、皮膚損傷修復上的協同功效，為漢方草本多醣的功效落地提供了堅實的科學依據。進一步鞏固了無限極在中草藥與多醣領域的科研領先地位。

During the academic sessions on November 7(th) and 8(th), Dr. Elaine Zhu, Senior R&D Specialist in Advanced Technologies at Infinitus (China) Company Limited, shared the latest breakthroughs in Ganoderma lucidum polysaccharide research with conference participants. Through source-level screening, the research team identified a high-quality strain, M624, and established a patented traceability system. In terms of processing technology, the team adopted an environmentally friendly approach combining membrane filtration and ultrasonic degradation to successfully produce GLP-D Ganoderma lucidum polysaccharides, which offer high water solubility, easy absorption and stable quality. The team also pioneered a distinctive oligosaccharide fingerprinting technique, further enhancing overall quality control standards. Furthermore, the research revealed the key mechanisms through which GLP-D polysaccharides regulate intestinal immunity and demonstrated the synergistic effects of compound polysaccharide formulations in in supporting anti-infection, anti-fatigue, and skin repair. These findings provide a solid scientific basis for translating the benefits of Chinese herbal polysaccharides into practical applications, further consolidating Infinitus's leading position in research on Chinese herbal medicine and polysaccharides.

無限極（中國）有限公司前沿技術高級研究員朱穎博士出席學術會議環節

Dr Elaine Zhu, Senior R&D Specialist in Advanced Technologies at Infinitus (China) Company Limited, attended the academic session.

此外，香港浸會大學─無限極中草藥多醣研究聯合實驗室早前發表的高水平論文《無標記多醣經腸道淋巴吸收後的動態分佈》刊載於國際權威期刊《International Journal of Biological Macromolecules》（IF8.7）。該研究依託聯合實驗室自主開發的特徵性寡醣技術，實現了黃芪多醣的體內追蹤，充分彰顯了聯合實驗室在中草藥多醣研究領域的科研實力與國際影響力。

In addition, a high-quality research paper previously published by the HKBU & Infinitus Joint Laboratory for Chinese Herbal Polysaccharide Research, entitled “Dynamic Distribution of Label-Free Polysaccharides After Intestinal Lymphatic Absorption”, was featured in the internationally renowned journal International Journal of Biological Macromolecules (IF8.7). Leveraging the Joint Laboratory’s proprietary oligosaccharide technology, the study successfully tracked the in vivo distribution of Astragalus polysaccharides, demonstrating the laboratory’s research capabilities and international standing in the field of Chinese herbal medicine polysaccharide research.

多醣研究創新獎 賦能青年科研力量

Polysaccharide Research Innovation Awards Empower the Next Generation of Researchers

本次活動無限極冠名設立「無限極多醣研究創新獎 – 青年學者獎」及「無限極多醣研究創新獎 – 優秀研究生獎」。設立該獎項的初心，源於無限極在複合多醣研究上的長期投入，以及對產學研技術創新的深切鼓勵。

本次評選依託大會學術委員會，透過公平公正的評選機制。經專業評選，共有10位青年學者及研究生獲此殊榮。無限極（中國）前沿技術研究總監陳亮博士（Dr. Pony Chen）與無限極海外市場總監許尉琳女士（Ms. Jacqueline Hui）特別出席頒獎儀式，親自為得獎者頒發榮譽。獲獎項目既涵蓋多醣領域的高水平研究，亦包含可遷移至多醣領域的前沿方法學成果，切實推動多醣研究發展，為學科的蓬勃未來注入新鮮力量。

As the exclusive sponsor, Infinitus established two awards at the conference: the “Infinitus Polysaccharide Research Innovation Award – Outstanding Young Scholar Presentation Award” and the “Infinitus Polysaccharide Research Innovation Award – Outstanding Postgraduate Presentation Award”. The initiative reflects Infinitus's long-standing investment in compound polysaccharide research and its strong commitment to encouraging technological innovation through industry–academia–research collaboration.

無限極（中國）前沿技術研究總監陳亮博士出席頒獎儀式，為得獎者頒獎

Dr Pony Chen, Research Director of Advanced Technologies at Infinitus (China), presenting awards at the ceremony

無限極海外市場總監許尉琳女士出席頒獎儀式，為得獎者頒獎

Ms. Jacqueline Hui, Director of Overseas Markets at Infinitus, presenting awards at the ceremony

實地探訪 打造專屬體驗

Exclusive Experiences Through First-hand Visits

11月9日，「香港浸會大學─無限極中草藥多醣研究聯合實驗室」人員特別為無限極香港業務夥伴量身定制了專屬行程。上午率先組織業務夥伴前往香港中醫院與不對公眾開放的政府中藥檢測中心進行深入參觀；下午的座談環節則詳細介紹了香港浸會大學中醫藥學院的行業權威地位、雙方合作背景，以及無限極在多醣研究上的獨特優勢；隨後夥伴們更親身進入聯合實驗室實地走訪，並於聯合實驗室牌匾及浸會大學校門合影留念，為本次專屬體驗留下珍貴紀錄。

On November 9(th), the researcher of HKBU & Infinitus Joint Laboratory for Chinese Herbal Polysaccharide Research specially arranged an exclusive itinerary for Infinitus's Hong Kong business partners. In the morning, the group visited the Chinese Medicine Hospital of Hong Kong and the Government Chinese Medicines Testing Institute, which is not generally open to the public, for an in-depth tour. During the afternoon discussion session, representatives provided a detailed introduction to the authoritative standing of HKBU's School of Chinese Medicine within the industry, the background to the partnership between the two parties, and Infinitus's distinctive strengths in polysaccharide research. The business partners subsequently had the opportunity to visit the HKBU & Infinitus Joint Laboratory in person. They also took commemorative photographs in front of the Joint Laboratory plaque and at the entrance to Hong Kong Baptist University, capturing lasting memories of this exclusive experience.

與業務夥伴於香港浸會大學校門前合影

Group photo with business partners in front of the entrance to Hong Kong Baptist University

科研賦能邁向未來 轉化成果造福大眾

Advancing the Future Through Research and Translating Findings into Benefits for All

本次香港系列活動不僅完美展現了無限極在前沿學術研究上的實力，更透過深度實地參訪、進行科研賦能業務夥伴的專屬體驗。面向未來，無限極將繼續深耕中草藥科技，把更多的前沿科研成果，轉化成看得見、用得上的中草藥健康產品，讓更多的人收穫健康與快樂。

The series of activities in Hong Kong not only showcased Infinitus's strong capabilities in cutting-edge academic research, but also offered business partners an exclusive experience to gain first-hand insights into scientific research through in-depth visits and exchanges. Looking ahead, Infinitus will continue to strengthen its commitment to research and development in Chinese herbal medicine technology, translating more cutting-edge research findings into tangible, practical and accessible Chinese herbal health products, enabling more people to enjoy health and happiness.

📣想了解更多養生資訊🌿 立即關注我們的最新頻道

FACEBOOK：https://w1AhMI.short.gy/4hFfWQ

IG：https://w1AhMI.short.gy/oqWcSu

微信公眾號：https://w1AhMI.short.gy/hawjEx